Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immuneering Corp | 135,441 | reported | 12 Jan 2026 | tx 32+949,670−338,835 |
| Vascular Biogenics Ltd. | 40,247 | reported | 08 May 2024 | tx 2+50,000 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 16 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | PURCHASE | Immuneering Corp | 20,000 | 4.35 USD | |
| 01 Jan 2026 | GRANT_AWARD | Immuneering Corp | 7,888 | 0.00 USD | deriv |
| 03 Oct 2025 | PURCHASE | Immuneering Corp | 7,500 | 6.67 USD | |
| 30 Sept 2025 | PURCHASE | Immuneering Corp | 7,500 | 7.03 USD | |
| 29 Sept 2025 | PURCHASE | Immuneering Corp | 5,000 | 7.18 USD | |
| 18 Jun 2025 | PURCHASE | Immuneering Corp | 25,000 | 2.53 USD | first after silence |
| 13 Jun 2025 | GRANT_AWARD | Immuneering Corp | 33,350 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Immuneering Corp | 23,485 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Immuneering Corp | 33,350 | 0.00 USD | deriv |
| 08 May 2024 | GRANT_AWARD | Vascular Biogenics Ltd. | 40,247 | 0.00 USD | |
| 22 Mar 2024 | PURCHASE | Immuneering Corp | 25,000 | 2.55 USD | |
| 18 Mar 2024 | PURCHASE | Immuneering Corp | 4,976 | 3.05 USD | |
| 19 Mar 2024 | PURCHASE | Immuneering Corp | 25,000 | 2.56 USD | |
| 18 Mar 2024 | PURCHASE | Immuneering Corp | 45,024 | 2.31 USD | first after silence |
| 24 Jan 2024 | GRANT_AWARD | Vascular Biogenics Ltd. | 9,753 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Immuneering Corp | 6,879 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Immuneering Corp | 17,500 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | Immuneering Corp | 14,200 | 0.00 USD | deriv |
| 15 Mar 2022 | PURCHASE | Immuneering Corp | 6,667 | 6.75 USD | |
| 20 Sept 2021 | PURCHASE | Immuneering Corp | 4,750 | 24.45 USD | |
| 13 Sept 2021 | PURCHASE | Immuneering Corp | 349 | 21.25 USD | |
| 13 Sept 2021 | PURCHASE | Immuneering Corp | 5,750 | 21.51 USD | |
| 03 Aug 2021 | CONVERSION | Immuneering Corp | 82,108 | — | |
| 03 Aug 2021 | PURCHASE | Immuneering Corp | 129,167 | 15.00 USD | anomaly |
| 03 Aug 2021 | CONVERSION | Immuneering Corp | 123,155 | — |
2 purchases reported after at least 12 months of silence — most recent on 18 Jun 2025.